Two years experience with recombinant Human DNase I in the treatment of pulmonary disease in cystic fibrosis

Lung Function Testing: Selection of Reference Values and Interpretative Strategies

American Review of Respiratory Disease · 1991 · 2.5K citations

Health Professions, Clinical Sciences, Internal Medicine +16

Standardization of Spirometry—1987 Update

American Review of Respiratory Disease · 1987 · 2.3K citations

Health Professions, Internal Medicine, Physiology +11

Effect of Aerosolized Recombinant Human DNase on Exacerbations of Respiratory Symptoms and on Pulmonary Function in Patients with Cystic Fibrosis

Henry J. Fuchs, Drucy Borowitz, David Høyrup Christiansen et al. · New England Journal of Medicine · 1994 · 1.5K citations · Full text

Life Sciences, Biotechnology, Molecular Biology +14

Prediction of Mortality in Patients with Cystic Fibrosis

Eitan Kerem, Joseph Reisman, Mary Corey et al. · New England Journal of Medicine · 1992 · 987 citations

Medicine, Clinical Sciences, Internal Medicine +17

The changing epidemiology of cystic fibrosis

Stacey C. FitzSimmons · The Journal of Pediatrics · 1993 · 933 citations

Medicine, Preventive Medicine, Clinical Epidemiology +7